Brief: PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted To SkinTE®
13/05/2022 13:12
May 13 (Reuters) - PolarityTE Inc PTE.O :
* POLARITYTE ANNOUNCES FDA REGENERATIVE MEDICINE ADVANCED
THERAPY
DESIGNATION GRANTED TO SKINTE®
* POLARITYTE INC - ANNOUNCED THAT FDA GRANTED A REGENERATIVE
MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION TO SKINTE UNDER
CO'S OPEN IND
Source text for Eikon: ID:nPn9YjTg9a
Further company coverage: PTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RegenETP,
See all newsBrief: PolarityTE Receives Delisting Notice From Nasdaq
U.S. STOCKS ON THE MOVE-Biogen, Phoenix Motor, Mastercard
U.S. STOCKS ON THE MOVE-Energy sector, Affirm, Stitch Fix
U.S. STOCKS ON THE MOVE-Shutterstock, Salesforce, Plug Power
Brief: Polarityte And Its Subsidiaries Files Voluntary Petitions For Relief Under Chapter 11